Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

NCT02442752 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Withdrawn: Business decision (no enrollment)

Conditions

Pediatric Gastroesophageal Reflux Disease

Interventions

DRUG: Dexlansoprazole

Sponsor

Takeda